Synergy and interactions among biological pathways leading to preterm premature rupture of membranes

Reproductive Sciences

Volumn 21, Issue 10, 2014, Pages 1215-1227

  Lannon, Sophia M R ^a   Vanderhoeven, Jeroen P ^b   Eschenbach, David A ^a   Gravett, Michael G ^a,c   Waldorf, Kristina M Adams ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b SWEDISH MEDICAL CENTER   (United States)

^c Global Alliance to Prevent Prematurity and Stillbirth   (United States)

Author keywords

abruption; chorioamnion; chorioamnionitis; fetal membranes; inflammation; intraamniotic infection; oxidative stress; PPROM; preterm birth; preterm premature rupture of membranes

Indexed keywords

COLLAGEN TYPE 3; DNA FRAGMENT; MATRIX METALLOPROTEINASE;

AMNION CELL; APOPTOSIS; BIOMECHANICS; BLEEDING; CHORIOAMNIONITIS; FETUS MEMBRANE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GROWTH, DEVELOPMENT AND AGING; HUMAN; INTERMEDIATE FILAMENT; MITOCHONDRIAL MEMBRANE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; REVIEW; RISK FACTOR; SHEAR STRENGTH; SMOKING; UTERUS; ANIMAL; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; METABOLISM; PHYSIOLOGY; PREGNANCY; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; HUMANS; OXIDATIVE STRESS; PREGNANCY; SIGNAL TRANSDUCTION;

EID: 84908866264     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719114534535     Document Type: Review

References (133)

1. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet. 2008; 371 ((9606)). 75-84
2. Liu L, Johnson HL, Cousens S, et al. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet. 2012; 379 ((9832)). 2151-2161
3. Ye G, Jiang Z, Lu S, Le Y. Premature infants born after preterm premature rupture of membranes with 24-34 weeks of gestation: a study of factors influencing length of neonatal intensive care unit stay. J Matern Fetal Neonatal Med. 2011; 24 ((7)). 960-965
4. Khashoggi TY. Outcome of pregnancies with preterm premature rupture of membranes. Saudi Med J. 2004; 25 ((12)). 1957-1961
5. Stewart CJ, Tregoning SK, Moller G, Wainwright H. Preterm prelabour rupture of the membranes before 28 weeks: better than feared outcome of expectant management in Africa. Eur J Obstet Gynecol Reprod Biol. 2006; 126 ((2)). 186-192
6. Noor S, Nazar AF, Bashir R, Sultana R. Prevalence of PPROM and its outcome. J Ayub Med Coll Abbottabad. 2007; 19 ((4)). 14-17
7. Obi SN, Ozumba BC. Pre-term premature rupture of fetal membranes: the dilemma of management in a developing nation. J Obstet Gynaecol. 2007; 27 ((1)). 37-40
8. Brace RA. Physiology of amniotic fluid volume regulation. Clin Obstetrics Gynecol. 1997; 40 ((2)). 280-289
9. Parry S, Strauss JF III. Premature rupture of the fetal membranes. N Engl J Med. 1998; 338 ((10)). 663-670
10. Oxlund H, Helmig R, Halaburt JT, Uldbjerg N. Biomechanical analysis of human chorioamniotic membranes. Eur J Obstet Gynecol Reprod Biol. 1990; 34 ((3)). 247-255
11. Arikat S, Novince RW, Mercer BM, et al. Separation of amnion from choriodecidua is an integral event to the rupture of normal term fetal membranes and constitutes a significant component of the work required. Am J Obstet Gynecol. 2006; 194 ((1)). 211-217
12. Ockleford C, Malak T, Hubbard A, et al. Confocal and conventional immunofluorescence and ultrastructural localisation of intracellular strength-giving components of human amniochorion. J Anat. 1993; 183 ((pt 3)). 483-505
13. Bourne G.. The foetal membranes. A review of the anatomy of normal amnion and chorion and some aspects of their function. Postgrad Med J. 1962; 38: 193-201
14. Bryant-Greenwood GD. The extracellular matrix of the human fetal membranes: structure and function. Placenta. 1998; 19 ((1)). 1-11
15. Malak TM, Bell SC. Structural characteristics of term human fetal membranes: a novel zone of extreme morphological alteration within the rupture site. Br J Obstet Gynaecol. 1994; 101 ((5)). 375-386
16. Meinert M, Eriksen GV, Petersen AC, Helmig RB, Laurent C, Uldbjerg N, et al. Proteoglycans and hyaluronan in human fetal membranes. American journal of obstetrics and gynecology. 2001; 184 ((4)). 679-85
17. Malak TM, Ockleford CD, Bell SC, Dalgleish R, Bright N, Macvicar J. Confocal immunofluorescence localization of collagen types I, III, IV, V and VI and their ultrastructural organization in term human fetal membranes. Placenta. 1993; 14 ((4)). 385-406
18. Hieber AD, Corcino D, Motosue J, et al. Detection of elastin in the human fetal membranes: proposed molecular basis for elasticity. Placenta. 1997; 18 ((4)). 301-312
19. Parry-Jones E, Priya S. A study of the elasticity and tension of fetal membranes and of the relation of the area of the gestational sac to the area of the uterine cavity. Br J Obstet Gynaecol. 1976; 83 ((3)). 205-212
20. Benirschke K, Kaufman P, Baergen RN Anatomy and Pathology of the Human Membranes. Pathology of the Human Placenta. 5 th ed. New York: Springer Science + Business Media, Inc.; 2006:321-379. New York: Springer Science + Business Media, Inc; 2006: 321-379.
21. Joyce EM, Moore JJ, Sacks MS. Biomechanics of the fetal membrane prior to mechanical failure: review and implications. Eur J Obstet Gynecol Reprod Biol. 2009; 144 ((suppl 1)). S121 - S127
22. Artal R, Sokol RJ, Neuman M, Burstein AH, Stojkov J. The mechanical properties of prematurely and non - prematurely ruptured membranes. Methods and preliminary results. Am J Obstet Gynecol. 1976; 125 ((5)). 655-659
23. Manabe Y, Himeno N, Fukumoto M. Tensile strength and collagen content of amniotic membrane do not change after the second trimester or during delivery. Obstet Gynecol. 1991; 78 ((1)). 24-27
24. El Khwad M, Stetzer B, Moore RM, et al. Term human fetal membranes have a weak zone overlying the lower uterine pole and cervix before onset of labor. Biol Reprod. 2005; 72 ((3)). 720-726
25. El Khwad M, Pandey V, Stetzer B, et al. Fetal membranes from term vaginal deliveries have a zone of weakness exhibiting characteristics of apoptosis and remodeling. J Soc Gynecol Investig. 2006; 13 ((3)). 191-195
26. Maclachlan TB. A Method for the investigation of the strength of the fetal membranes. Am J Obstet Gynecol. 1965; 91: 309-313
27. Rangaswamy N, Abdelrahim A, Moore RM, et al. Biomechanical characteristics of human fetal membranes. Preterm fetal membranes are stronger than term fetal membranes [in French]. Gynecol Obstet Fertil. 2011; 39 ((6)). 373-377
28. Polishuk WZ, Kohane S, Pernaio A. The physical properties of fetal membranes. Obstet Gynecol. 1962; 20 ((2)). 204-210
29. Lavery JP, Miller CE. The viscoelastic nature of chorioamniotic membranes. Obstet Gynecol. 1977; 50 ((4)). 467-472
30. Lavery JP, Miller CE. Deformation and creep in the human chorioamniotic sac. Am J Obstet Gynecol. 1979; 134 ((4)). 366-375
31. Oyen ML, Cook RF, Calvin SE. Mechanical failure of human fetal membrane tissues. J Mater Sci Mater Med. 2004; 15 ((6)). 651-658
32. Schober EA, Kusy RP, Whitley JQ, Savitz DA. Effect of thickness on the fracture characteristics of fetal membranes. J Mater Sci Mater Med. 1994; 5 ((3)). 130-137
33. Oyen ML, Calvin SE, Landers DV. Premature rupture of the fetal membranes: is the amnion the major determinant?. Am J Obstet Gynecol. 2006; 195 ((2)). 510-515
34. Canzoneri BJ, Feng L, Grotegut CA, Bentley RC, Heine RP, Murtha AP. The chorion layer of fetal membranes is prematurely destroyed in women with preterm premature rupture of the membranes. Reprod Sci. 2013; 20 (10). 1246-1254
35. Strauss JF III. Extracellular matrix dynamics and fetal membrane rupture. Reprod Sci. 2013; 20 ((2)). 140-153
36. Biggio JR, Ramsey PS, Cliver SP, Lyon MD, Goldenberg RL, Wenstrom KD. Midtrimester amniotic fluid matrix metalloproteinase-8 (MMP-8) levels above the 90th percentile are a marker for subsequent preterm premature rupture of membranes. Am J Obstet Gynecol. 2005; 192 ((1)). 109-113
37. Athayde N, Edwin SS, Romero R, et al. A role for matrix metalloproteinase-9 in spontaneous rupture of the fetal membranes. Am J Obstet Gynecol. 1998; 179 ((5)). 1248-1253
38. Menon R, Fortunato SJ. The role of matrix degrading enzymes and apoptosis in rupture of membranes. J Soc Gynecol Investig. 2004; 11 ((7)). 427-437
39. Menon R, Fortunato SJ. Infection and the role of inflammation in preterm premature rupture of the membranes. Best Pract Res Clin Obstet Gynaecol. 2007; 21 ((3)). 467-478
40. Paavola LG, Furth EE, Delgado V, et al. Striking changes in the structure and organization of rat fetal membranes precede parturition. Biol Reprod. 1995; 53 ((2)). 321-338
41. Saglam A, Ozgur C, Derwig I, Unlu BS, Gode F, Mungan T. The role of apoptosis in preterm premature rupture of the human fetal membranes. Arch Gynecol Obstet. 2013; 288 ((3)). 501-505
42. Fortunato SJ, Menon R, Bryant C, Lombardi SJ. Programmed cell death (apoptosis) as a possible pathway to metalloproteinase activation and fetal membrane degradation in premature rupture of membranes. Am J Obstet Gynecol. 2000; 182 ((6)). 1468-1476
43. Fortunato SJ, Menon R, Lombardi SJ. Support for an infection-induced apoptotic pathway in human fetal membranes. Am J Obstet Gynecol. 2001; 184 ((7)). 1392-1397
44. Menon R, Fortunato SJ, Yu J, et al. Cigarette smoke induces oxidative stress and apoptosis in normal term fetal membranes. Placenta. 2011; 32 ((4)). 317-322
45. Longini M, Perrone S, Vezzosi P, et al. Association between oxidative stress in pregnancy and preterm premature rupture of membranes. Clin Biochem. 2007; 40 ((11)). 793-797
46. Woods JR. Reactive oxygen species and preterm premature rupture of membranes-a review. Placenta. 2001; 22 ((suppl A)). S38 - S44
47. Barrera G.. Oxidative Stress and Lipid Peroxidation Products in Cancer Progression and Therapy. ISRN Oncology. 2012;:
48. Plessinger MA, Woods JR, Miller RK. Pretreatment of human amnion-chorion with vitamins C and E prevents hypochlorous acid-induced damage. Am J Obstet Gynecol. 2000; 183 ((4)). 979-985
49. Mercer BM, Abdelrahim A, Moore RM, et al. The impact of vitamin C supplementation in pregnancy and in vitro upon fetal membrane strength and remodeling. Reprod Sci. 2010; 17 ((7)). 685-695
50. Spinnato JA II, Freire S, Pinto e Silva JL, et al. Antioxidant supplementation and premature rupture of the membranes: a planned secondary analysis. Am J Obstet Gynecol. 2008; 199 (4). e1 - e8
51. Moore RM, Schatz F, Kumar D, et al. Alpha-lipoic acid inhibits thrombin-induced fetal membrane weakening in vitro. Placenta. 2010; 31 ((10)). 886-892
52. Lim R, Barker G, Wall CA, Lappas M. Dietary phytophenols curcumin, naringenin and apigenin reduce infection-induced inflammatory and contractile pathways in human placenta, foetal membranes and myometrium. Mol Hum Reprod. 2013; 19 ((7)). 451-462
53. Joaquin SF, Romero R, Espinoza J, et al Clinical Obstetrics: The Fetus and The Mother. 3 rd ed. Malden, MA: Blackwell Publishing; 2007:1130-1188. Reece EA John CH, ed. Malden, MA: Blackwell Publishing; 2007: 1130-1188.
54. Garite TJ, Freeman RK, Linzey EM, Braly P. The use of amniocentesis in patients with premature rupture of membranes. Obstet Gynecol. 1979; 54 ((2)). 226-230
55. Romero R, Quintero R, Oyarzun E, et al. Intraamniotic infection and the onset of labor in preterm premature rupture of the membranes. Am J Obstet Gynecol. 1988; 159 ((3)). 661-666
56. Kim KW, Romero R, Park HS, et al. A rapid matrix metalloproteinase-8 bedside test for the detection of intraamniotic inflammation in women with preterm premature rupture of membranes. Am J Obstet Gynecol. 2007; 197 (3). e1 - e5
57. Shim SS, Romero R, Hong JS, et al. Clinical significance of intra-amniotic inflammation in patients with preterm premature rupture of membranes. Am J Obstet Gynecol. 2004; 191 ((4)). 1339-1345
58. Romero R, Baumann P, Gomez R, et al. The relationship between spontaneous rupture of membranes, labor, and microbial invasion of the amniotic cavity and amniotic fluid concentrations of prostaglandins and thromboxane B2 in term pregnancy. Am J Obstet Gynecol. 1993; 168 ((6 pt 1)). 1654-1664
59. DiGiulio DB, Romero R, Kusanovic JP, et al. Prevalence and diversity of microbes in the amniotic fluid, the fetal inflammatory response, and pregnancy outcome in women with preterm pre-labor rupture of membranes. Am J Reprod Immunol. 2010; 64 ((1)). 38-57
60. Hillier SL, Krohn MA, Kiviat NB, Watts DH, Eschenbach DA. Microbiologic causes and neonatal outcomes associated with chorioamnion infection. Am J Obstet Gynecol. 1991; 165 ((4 pt 1)). 955-961
61. Guinn DA, Goldenberg RL, Hauth JC, Andrews WW, Thom E, Romero R. Risk factors for the development of preterm premature rupture of the membranes after arrest of preterm labor. Am J Obstet Gynecol. 1995; 173 ((4)). 1310-1315
62. McDonald HM, O'Loughlin JA, Jolley PT, Vigneswaran R, McDonald PJ. Changes in vaginal flora during pregnancy and association with preterm birth. J Infect Dis. 1994; 170 ((3)). 724-728
63. Regan JA, Chao S, James LS. Premature rupture of membranes, preterm delivery, and group B streptococcal colonization of mothers. Am J Obstet Gynecol. 1981; 141 ((2)). 184-186
64. Alger LS, Lovchik JC, Hebel JR, Blackmon LR, Crenshaw MC. The association of Chlamydia trachomatis, Neisseria gonorrhoeae, and group B streptococci with preterm rupture of the membranes and pregnancy outcome. Am J Obstetrics Gynecol. 1988; 159 ((2)). 397-404
65. Ekwo EE, Gosselink CA, Woolson R, Moawad A. Risks for premature rupture of amniotic membranes. Int J Epidemiol. 1993; 22 ((3)). 495-503
66. Cotch MF, Pastorek JG II, Nugent RP, et al. Trichomonas vaginalis associated with low birth weight and preterm delivery. The vaginal infections and prematurity study group. Sex Transm Dis. 1997; 24 ((6)). 353-360
67. Whidbey C, Harrell MI, Burnside K, et al. A hemolytic pigment of Group B Streptococcus allows bacterial penetration of human placenta. J Exp Med in press. 2013; 210 ((6)). 1265-1281
68. Cobo T, Kacerovsky M, Palacio M, et al. Intra-amniotic inflammatory response in subgroups of women with preterm prelabor rupture of the membranes. PloS ONE. 2012; 7 ((8)). e43677
69. Fortunato SJ, Menon R, Lombardi SJ. Role of tumor necrosis factor-alpha in the premature rupture of membranes and preterm labor pathways. Am J Obstet Gynecol. 2002; 187 ((5)). 1159-1162
70. Jacobsson B, Aaltonen R, Rantakokko-Jalava K, Morken NH, Alanen A. Quantification of Ureaplasma urealyticum DNA in the amniotic fluid from patients in PTL and pPROM and its relation to inflammatory cytokine levels. Acta obstetricia et gynecologica Scandinavica. 2009; 88 ((1)). 63-70
71. Romero R, Mazor M, Sepulveda W, Avila C, Copeland D, Williams J. Tumor necrosis factor in preterm and term labor. Am J Obstet Gynecol. 1992; 166 ((5)). 1576-1587
72. Yui J, Garcia-Lloret M, Wegmann TG, Guilbert LJ. Cytotoxicity of tumour necrosis factor-alpha and gamma-interferon against primary human placental trophoblasts. Placenta. 1994; 15 ((8)). 819-835
73. Kumar D, Schatz F, Moore RM, et al. The effects of thrombin and cytokines upon the biomechanics and remodeling of isolated amnion membrane, in vitro. Placenta. 2011; 32 (3). 206-213
74. Li W, Unlugedik E, Bocking AD, Challis JR. The role of prostaglandins in the mechanism of lipopolysaccharide-induced proMMP9 secretion from human placenta and fetal membrane cells. Biol Reprod. 2007; 76 ((4)). 654-659
75. McLaren J, Taylor DJ, Bell SC. Prostaglandin E(2)-dependent production of latent matrix metalloproteinase-9 in cultures of human fetal membranes. Mol Hum Reprod. 2000; 6 (11). 1033-1040
76. Ulug U, Goldman S, Ben-Shlomo I, Shalev E. Matrix metalloproteinase (MMP)-2 and MMP-9 and their inhibitor, TIMP-1, in human term decidua and fetal membranes: the effect of prostaglandin F(2alpha) and indomethacin. Mol Hum Reprod. 2001; 7 (12). 1187-1193
77. Kodali R, Hajjou M, Berman AB, et al. Chemokines induce matrix metalloproteinase-2 through activation of epidermal growth factor receptor in arterial smooth muscle cells. Cardiovasc Res. 2006; 69 ((3)). 706-715
78. Groom KM, Shennan AH, Jones BA, Seed P, Bennett PR. TOCOX - a randomised, double-blind, placebo-controlled trial of rofecoxib (a COX-2-specific prostaglandin inhibitor) for the prevention of preterm delivery in women at high risk. BJOG. 2005; 112 ((6)). 725-730
79. Khanprakob T, Laopaiboon M, Lumbiganon P, Sangkomkamhang US. Cyclo-oxygenase (COX) inhibitors for preventing preterm labour. Cochrane Database Syst Rev. 2012; 10: CD007748
80. Vanderhoeven JP, Bierle CJ, Kapur RP, et al. Group B streptococcal infection of the choriodecidua induces dysfunction of the cytokeratin network in amniotic epithelium: a pathway to membrane weakening. PLoS Pathog. 2014; 10 (3). e1003920
81. Jones HE, Harris KA, Azizia M, et al. Differing prevalence and diversity of bacterial species in fetal membranes from very preterm and term labor. PLoS One. 2009; 4 ((12)). e8205
82. DiGiulio DB, Romero R, Amogan HP, et al. Microbial prevalence, diversity and abundance in amniotic fluid during preterm labor: a molecular and culture-based investigation. PLoS One. 2008; 3 ((8)). e3056
83. Han YW, Shen T, Chung P, Buhimschi IA, Buhimschi CS. Uncultivated bacteria as etiologic agents of intra-amniotic inflammation leading to preterm birth. J Clin Microbiol. 2009; 47 ((1)). 38-47
84. Stout MJ, Conlon B, Landeau M, et al. Identification of intracellular bacteria in the basal plate of the human placenta in term and preterm gestations. Am J Obstet Gynecol. 2013; 208 (3). e1 - e7
85. Stephenson CD, Lockwood CJ, Ma Y, Guller S. Thrombin-dependent regulation of matrix metalloproteinase (MMP)-9 levels in human fetal membranes. J Matern Fetal Neona. 2005; 18 ((1)). 17-22
86. Chen D, Dorling A. Critical roles for thrombin in acute and chronic inflammation. J Thromb Haemost. 2009; 7 ((suppl 1)). 122-126
87. Park KW, Jin BK. Thrombin-induced oxidative stress contributes to the death of hippocampal neurons: role of neuronal NADPH oxidase. J Neurosci Res. 2008; 86 ((5)). 1053-1063
88. Lopez JJ, Salido GM, Gomez-Arteta E, Rosado JA, Pariente JA. Thrombin induces apoptotic events through the generation of reactive oxygen species in human platelets. J Thromb Haemost. 2007; 5 ((6)). 1283-1291
89. Harger JH, Hsing AW, Tuomala RE, et al. Risk factors for preterm premature rupture of fetal membranes: a multicenter case-control study. Am J Obstet Gynecol. 1990; 163 ((1 pt 1)). 130-137
90. Erez O, Espinoza J, Chaiworapongsa T, et al. A link between a hemostatic disorder and preterm PROM: a role for tissue factor and tissue factor pathway inhibitor. J Matern Fetal Neona. 2008; 21 ((10)). 732-744
91. Rosen T, Kuczynski E, O'Neill LM, Funai EF, Lockwood CJ. Plasma levels of thrombin-antithrombin complexes predict preterm premature rupture of the fetal membranes. J Maternal Fetal Med. 2001; 10 ((5)). 297-300
92. Rosen T, Schatz F, Kuczynski E, Lam H, Koo AB, Lockwood CJ. Thrombin-enhanced matrix metalloproteinase-1 expression: a mechanism linking placental abruption with premature rupture of the membranes. J Matern Fetal Neona. 2002; 11 ((1)). 11-17
93. Matta P, Lockwood CJ, Schatz F, et al. Thrombin regulates monocyte chemoattractant protein-1 expression in human first trimester and term decidual cells. Am J Obstet Gynecol. 2007; 196 (3). e1 - e8
94. Puthiyachirakkal M, Lemerand K, Kumar D, et al. Thrombin weakens the amnion extracellular matrix (ECM) directly rather than through protease activated receptors. Placenta. 2013; 34 ((10)). 924-931
95. England MC, Benjamin A, Abenhaim HA. Increased risk of preterm premature rupture of membranes at early gestational ages among maternal cigarette smokers. Am J Perinatol. 2013; 30 ((10)). 821-826
96. Henderson JJ, McWilliam OA, Newnham JP, Pennell CE. Preterm birth aetiology 2004-2008. Maternal factors associated with three phenotypes: spontaneous preterm labour, preterm pre-labour rupture of membranes and medically indicated preterm birth. J Matern Fetal Neona. 2012; 25 ((6)). 642-647
97. Burlingame JM, Esfandiari N, Sharma RK, Mascha E, Falcone T. Total antioxidant capacity and reactive oxygen species in amniotic fluid. Obstet Gynecol. 2003; 101 ((4)). 756-761
98. Falk SJ, Campbell LJ, Lee-Parritz A, et al. Expectant management in spontaneous preterm premature rupture of membranes between 14 and 24 weeks' gestation. J Perinatol. 2004; 24 ((10)). 611-616
99. Sooranna SR, Lee Y, Kim LU, Mohan AR, Bennett PR, Johnson MR. Mechanical stretch activates type 2 cyclooxygenase via activator protein-1 transcription factor in human myometrial cells. Mol Hum Reprod. 2004; 10 ((2)). 109-113
100. Terzidou V, Sooranna SR, Kim LU, Thornton S, Bennett PR, Johnson MR. Mechanical stretch up-regulates the human oxytocin receptor in primary human uterine myocytes. J Clin Endocrinol Metab. 2005; 90 ((1)). 237-246
101. Loudon JA, Sooranna SR, Bennett PR, Johnson MR. Mechanical stretch of human uterine smooth muscle cells increases IL-8 mRNA expression and peptide synthesis. Mol Hum Reprod. 2004; 10 ((12)). 895-899
102. Hua R, Pease JE, Sooranna SR, et al. Stretch and inflammatory cytokines drive myometrial chemokine expression via NF-kappaB activation. Endocrinology. 2012; 153 ((1)). 481-491
103. Zhao Y, Koga K, Osuga Y, et al. Cyclic stretch augments production of neutrophil chemokines and matrix metalloproteinases-1 (MMP-1) from human decidual cells, and the production was reduced by progesterone. Am J Reprod Immunol. 2013; 69 ((5)). 454-462
104. Durnwald CP, Momirova V, Rouse DJ, et al. Second trimester cervical length and risk of preterm birth in women with twin gestations treated with 17-alpha hydroxyprogesterone caproate. J Matern Fetal Neona. 2010; 23 ((12)). 1360-1364
105. Manabe Y, Manabe A, Takahashi A. F prostaglandin levels in amniotic fluid during balloon-induced cervical softening and labor at term. Prostaglandins. 1982; 23 ((2)). 247-256
106. Anum EA, Hill LD, Pandya A, Strauss JF III. Connective tissue and related disorders and preterm birth: clues to genes contributing to prematurity. Placenta. 2009; 30 ((3)). 207-215
107. Barabas AP. Ehlers-Danlos syndrome: associated with prematurity and premature rupture of foetal membranes; possible increase in incidence. Br Med J. 1966; 2 ((5515)). 682-684
108. Rossiter JP, Repke JT, Morales AJ, Murphy EA, Pyeritz RE. A prospective longitudinal evaluation of pregnancy in the Marfan syndrome. Am J Obstet Gynecol. 1995; 173 ((5)). 1599-1606
109. Rocnik EF, van der Veer E, Cao H, Hegele RA, Pickering JG. Functional linkage between the endoplasmic reticulum protein Hsp47 and procollagen expression in human vascular smooth muscle cells. J Biol Chem. 2002; 277 ((41)). 38571-38578
110. Wang H, Parry S, Macones G, et al. A functional SNP in the promoter of the SERPINH1 gene increases risk of preterm premature rupture of membranes in African Americans. Proc Natl Acad Sci U S A. 2006; 103 ((36)). 13463-13467
111. Fujimoto T, Parry S, Urbanek M, et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 (MMP-1) promoter influences amnion cell MMP-1 expression and risk for preterm premature rupture of the fetal membranes. J Biol Chem. 2002; 277 ((8)). 6296-6302
112. Kalish RB, Nguyen DP, Vardhana S, Gupta M, Perni SC, Witkin SS. A single nucleotide A>G polymorphism at position -670 in the Fas gene promoter: relationship to preterm premature rupture of fetal membranes in multifetal pregnancies. Am J Obstet Gynecol. 2005; 192 ((1)). 208-212
113. Kalish RB, Vardhana S, Normand NJ, Gupta M, Witkin SS. Association of a maternal CD14 -159 gene polymorphism with preterm premature rupture of membranes and spontaneous preterm birth in multi-fetal pregnancies. J Reprod Immunol. 2006; 70 ((1-2)). 109-117
114. Annells MF, Hart PH, Mullighan CG, et al. Interleukins-1, -4, -6, -10, tumor necrosis factor, transforming growth factor-beta, FAS, and mannose-binding protein C gene polymorphisms in Australian women: Risk of preterm birth. Am J Obstet Gynecol. 2004; 191 ((6)). 2056-2067
115. Roberts AK, Monzon-Bordonaba F, Van Deerlin PG, et al. Association of polymorphism within the promoter of the tumor necrosis factor alpha gene with increased risk of preterm premature rupture of the fetal membranes. Am J Obstet Gynecol. 1999; 180 ((5)). 1297-1302
116. Fuks A, Parton LA, Polavarapu S, et al. Polymorphism of Fas and Fas ligand in preterm premature rupture of membranes in singleton pregnancies. Am J Obstet Gynecol. 2005; 193 ((3 pt 2)). 1132-1136
117. Romero R, Friel LA, Velez Edwards DR, et al. A genetic association study of maternal and fetal candidate genes that predispose to preterm prelabor rupture of membranes (PROM). Am J Obstet Gynecol. 2010; 203 (4). e1 - e30
118. Asrat T, Lewis DF, Garite TJ, et al. Rate of recurrence of preterm premature rupture of membranes in consecutive pregnancies. Am J Obstet Gynecol. 1991; 165 ((4 pt 1)). 1111-1115
119. Ekwo EE, Gosselink CA, Moawad A. Unfavorable outcome in penultimate pregnancy and premature rupture of membranes in successive pregnancy. Obstet Gynecol. 1992; 80 ((2)). 166-172
120. Lee T, Carpenter MW, Heber WW, Silver HM. Preterm premature rupture of membranes: Risks of recurrent complications in the next pregnancy among a population-based sample of gravid women. Am J Obstet Gynecol. 2003; 188 ((1)). 209-213
121. Mercer BM, Goldenberg RL, Meis PJ, et al. The preterm prediction study: prediction of preterm premature rupture of membranes through clinical findings and ancillary testing. the national institute of child health and human development maternal-fetal medicine units network. Am J Obstet Gynecol. 2000; 183 ((3)). 738-745
122. Keirse MJ. Progestogen administration in pregnancy may prevent preterm delivery. Br J Obstet Gynaecol. 1990; 97 ((2)). 149-154
123. Meis PJ, Klebanoff M, Thom E, et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med. 2003; 348 ((24)). 2379-2385
124. da Fonseca EB, Bittar RE, Carvalho MH, Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol. 2003; 188 ((2)). 419-424
125. O'Brien JM, Adair CD, Lewis DF, et al. Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol. 2007; 30 ((5)). 687-696
126. Fonseca EB, Celik E, Parra M, Singh M, Nicolaides KH. Fetal Medicine Foundation Second Trimester Screening G. Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med. 2007; 357 ((5)). 462-469
127. Rouse DJ, Caritis SN, Peaceman AM, et al. A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins. N Engl J Med. 2007; 357 ((5)). 454-461
128. Keirse MJ. Progesterone and preterm: seventy years of "deja vu" or "still to be seen"?. Birth. 2004; 31 ((3)). 230-235
129. Briery CM, Veillon EW, Klauser CK, et al. Women with preterm premature rupture of the membranes do not benefit from weekly progesterone. Am J Obstet Gynecol. 2011; 204 (1). e1 - e5
130. Merlino A, Welsh T, Erdonmez T, et al. Nuclear progesterone receptor expression in the human fetal membranes and decidua at term before and after labor. Reprod Sci. 2009; 16 ((4)). 357-363
131. Sfakianaki AK, Norwitz ER. Mechanisms of progesterone action in inhibiting prematurity. J Matern Fetal Neonatal Med. 2006; 19 ((12)). 763-772
132. Iams JD, Romero R, Culhane JF, Goldenberg RL. Primary, secondary, and tertiary interventions to reduce the morbidity and mortality of preterm birth. Lancet. 2008; 371 ((9607)). 164-175
133. Luo G, Abrahams VM, Tadesse S, et al. Progesterone inhibits basal and TNF-alpha-induced apoptosis in fetal membranes: a novel mechanism to explain progesterone-mediated prevention of preterm birth. Reprod Sci. 2010; 17 ((6)). 532-539